Does high field MRI allow an earlier diagnosis of multiple sclerosis?

Mike P Wattjes1, Michael Harzheim, Götz G Lutterbey

  • 1Dept. of Radiology/Neuroradiology, University of Bonn, Bonn, Germany. m.wattjes@vumc.nl

Abstract

Insights

High field MRI detects more brain lesions in early demyelination, but does not speed up the diagnosis of definite multiple sclerosis (MS) using current criteria.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimaging

Background:

  • High field magnetic resonance imaging (MRI) offers improved detection of lesion load in patients with clinically isolated syndromes (CIS) suggestive of demyelination.
  • This enhanced detection impacts the classification of CIS and the potential diagnosis of multiple sclerosis (MS).

Purpose of the Study:

  • To determine if high field MRI can facilitate an earlier diagnosis of definite MS based on the International Panel (IP) and Swanton criteria.

Main Methods:

  • Forty patients with CIS underwent multi-sequence MRI at 1.5T and 3T, alongside neurological assessments.
  • Follow-up assessments, including MRI and neurological exams, were conducted at 3-4 and 6-7 months post-initial event.
  • Diagnosis was evaluated using fulfilled IP and Swanton criteria based on MRI and clinical findings.

Main Results:

  • High field MRI increased Swanton criteria classifications in 15% of patients at baseline due to higher inflammatory lesion detection.
  • One additional patient met dissemination in space criteria (Swanton and IP) at baseline.
  • Despite increased lesion detection, high field MRI did not enable an earlier diagnosis of definite MS according to either IP or Swanton criteria during follow-up.

Conclusions:

  • High field MRI enhances the detection of inflammatory brain lesions in CIS and MS patients, influencing MRI-based criteria.
  • However, this improved detection does not translate to an earlier diagnosis of lesion dissemination in time or definite MS.